Viyash Scientific Limited (NSE:VIYASH)
260.35
+1.25 (0.48%)
Sep 3, 2026, 3:15 PM IST
Viyash Scientific Company Description
Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry.
The company was formerly known as Sequent Scientific Limited and changed its name to Viyash Scientific Limited in January 2026.
The company was incorporated in 1985 and is headquartered in Hyderabad, India. Viyash Scientific Limited operates as a subsidiary of CA Harbor Investments.
Viyash Scientific Limited
| Country | India |
| Founded | 1985 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,900 |
| CEO | Hari Bodepudi |
Contact Details
Address: Srivallis Corporate Hyderabad, 500033 India | |
| Phone | 91 40 2363 5000 |
| Website | viyash.com |
Stock Details
| Ticker Symbol | VIYASH |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE807F01027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rajaram Narayanan | Chief Executive Officer of Animal Health and Whole-Time Executive Director |
| Dr. Hari Babu Bodepudi | MD, Group Chief Executive Officer and Executive Director |
| Srinivas Vasireddy | SVice President, Head of API Operations and Whole-Time Executive Director |
| Ramakant Singani | Chief Financial Officer |
| Ramesh Kumar Pillai | Corporate Vice President of Ra Qa and Technical Services |
| Ravi Nair | Executive Vice President of Human Resources and Administration |
| Abhishek Singhal | Head of Investor Relations |
| Phillip Trott | AVice President of Legal and Compliance, Head of Legal & Chief Risk Officer |
| Yoshita Vora | Company Secretary and Compliance Officer |
| Alexis Goux | Head of Global Formulations |